Antiviral effects of selected nucleoside analogues against human parechoviruses A1 and A3

Antiviral Res. 2019 Feb:162:51-53. doi: 10.1016/j.antiviral.2018.12.009. Epub 2018 Dec 12.

Abstract

Parechoviruses A (HPeV, Picornaviridae) are neglected human pathogens that cause sepsis-like illness and severe neurological complications in infants. There are no antivirals available for the treatment of HPeV infections. We here report on cell-based assays that allow for medium-throughput antiviral screening of compound libraries against HPeV. The nucleoside viral polymerase inhibitor 2'-C-methylcytidine was identified as being an in vitro replication inhibitor of HPeV1 and HPeV3 that can serve as a reference molecule for further antiviral studies.

Keywords: Antivirals; Human parechovirus; Picornaviruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Animals
  • Antiviral Agents / chemistry
  • Antiviral Agents / pharmacology*
  • Chlorocebus aethiops
  • HeLa Cells
  • High-Throughput Screening Assays
  • Humans
  • Mice
  • Nucleosides / pharmacology*
  • Parechovirus / drug effects*
  • Parechovirus / physiology
  • Vero Cells
  • Virus Replication / drug effects

Substances

  • Antiviral Agents
  • Nucleosides